Search

everythinglearnresearchcommunity

for

Search:↓

Southern Chinese women with female pattern hair loss have less, thinner hair and smaller hair follicles.

Hair loss is caused by genetics and hormones, diagnosed through examination and biopsy, and treated with medications or surgery.

The British Association of Dermatologists celebrated 100 years by looking back at important research, including work on hair loss, skin condition impact, psoriasis treatment, and skin cancer rates.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Follicular unit hair transplantation is the standard method for natural-looking hair restoration in androgenic alopecia.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Women with AGA have less hair on midscalp, more thin and non-growing hair.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Mast cells might contribute to hair loss by causing skin thickening.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Mesenchymal stem cell-derived exosomes significantly increase hair density and thickness in androgenic alopecia patients.

Hair restoration can be achieved through non-surgical treatments like minoxidil, antiandrogens, phototherapy, and PRP procedures, or through surgical methods like hair transplantation. Continued treatment is needed to maintain results, and full results are visible after 12-18 months.

Platelet-rich plasma injections are a cheap and effective way to reduce hair loss and improve hair quality in people with mild to moderate androgenetic alopecia.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Hair diameter diversity is a key sign for diagnosing and managing male pattern baldness.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.

PRP injections improve hair density and thickness in women with hair loss.

Laser treatment increases hair density and thickness safely in women with hair loss.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

The QR 678 hair growth treatment was safe and effective for hair regrowth in men and women.

PRP and cell therapies may help with hair loss, but more research is needed.